Unknown

Dataset Information

0

Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis.


ABSTRACT: Emerging evidences about gut-microbial modulation have been accumulated in the treatment of nonalcoholic fatty liver disease (NAFLD). We evaluated the effect of Bifidobacterium breve and Bifidobacterium longum on the NAFLD pathology and explore the molecular mechanisms based on multi-omics approaches. Human stool analysis [healthy subjects (n = 25) and NAFLD patients (n = 32)] was performed to select NAFLD-associated microbiota. Six-week-old male C57BL/6 J mice were fed a normal chow diet (NC), Western diet (WD), and WD with B. breve (BB) or B. longum (BL; 109 CFU/g) for 8 weeks. Liver/body weight ratio, histopathology, serum/tool analysis, 16S rRNA-sequencing, and metabolites were examined and compared. The BB and BL groups showed improved liver histology and function based on liver/body ratios (WD 7.07 ± 0.75, BB 5.27 ± 0.47, and BL 4.86 ± 0.57) and NAFLD activity scores (WD 5.00 ± 0.10, BB 1.89 ± 1.45, and BL 1.90 ± 0.99; p < 0.05). Strain treatment showed ameliorative effects on gut barrier function. Metagenomic analysis showed treatment-specific changes in taxonomic composition. The community was mainly characterized by the significantly higher composition of the Bacteroidetes phylum among the NC and probiotic-feeding groups. Similarly, the gut metabolome was modulated by probiotics treatment. In particular, short-chain fatty acids and tryptophan metabolites were reverted to normal levels by probiotics, whereas bile acids were partially normalized to those of the NC group. The analysis of gene expression related to lipid and glucose metabolism as well as the immune response indicated the coordinative regulation of β-oxidation, lipogenesis, and systemic inflammation by probiotic treatment. BB and BL attenuate NAFLD by improving microbiome-associated factors of the gut-liver axis.

SUBMITTER: Yoon SJ 

PROVIDER: S-EPMC10014915 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>Bifidobacterium</i>-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis.

Yoon Sang Jun SJ   Yu Jeong Seok JS   Min Byeong Hyun BH   Gupta Haripriya H   Won Sung-Min SM   Park Hee Jin HJ   Han Sang Hak SH   Kim Byung-Yong BY   Kim Kyung Hwan KH   Kim Byoung Kook BK   Joung Hyun Chae HC   Park Tae-Sik TS   Ham Young Lim YL   Lee Do Yup DY   Suk Ki Tae KT  

Frontiers in microbiology 20230301


Emerging evidences about gut-microbial modulation have been accumulated in the treatment of nonalcoholic fatty liver disease (NAFLD). We evaluated the effect of <i>Bifidobacterium breve</i> and <i>Bifidobacterium longum</i> on the NAFLD pathology and explore the molecular mechanisms based on multi-omics approaches. Human stool analysis [healthy subjects (<i>n</i> = 25) and NAFLD patients (<i>n</i> = 32)] was performed to select NAFLD-associated microbiota. Six-week-old male C57BL/6 J mice were f  ...[more]

Similar Datasets

| S-EPMC5481642 | biostudies-literature
| S-EPMC4970250 | biostudies-other
| S-EPMC5933768 | biostudies-literature
| S-EPMC5191969 | biostudies-literature
| S-EPMC4491606 | biostudies-literature
| S-EPMC10446130 | biostudies-literature
| S-EPMC6613006 | biostudies-literature
| S-EPMC4329055 | biostudies-literature
| S-EPMC6367993 | biostudies-literature
| S-EPMC10841017 | biostudies-literature